Our results support the finding that tirzepatide provides robust glycemic benefits in a population with diabetes and chronic kidney disease
Novo is running the Phase III EVOKE and EVOKE Plus trials to test semaglutide in patients with early Alzheimers disease
For individuals with a body mass index (BMI) of 30 kg/m or above (or 27.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds), NICE recommends considering pharmacological interventions alongside lifestyle changes when dietary and exercise modifications alone have been insufficient
If your real goal is fewer dark spots, less redness, or a smoother tone, you may get more from skin services that target those concerns without forcing melanin
CJC-1295 / Ipamorelin results timeline What research describes changing over weeks